---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-035600"
form_type: "8-K"
ticker: "PIII"
cik: "0001832511"
company_name: "P3 Health Partners Inc."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:52:55.700389+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# P3 Health Partners Q2 revenue up 15% to $379.2M; net loss widens to $28.8M

## Summary
- Total revenue $379.2M (+15% YoY); capitated revenue $374.3M (+15% YoY).
- Gross profit $14.0M (down from $26.8M); medical margin $41.1M (down from $50.5M).
- Net loss $28.8M (vs $27.6M); Adjusted EBITDA loss $8.8M (vs +$0.2M).
- FY2024 guidance: revenue $1.45-$1.55B; medical margin $230-$250M; Adjusted EBITDA $20-$40M.
- CEO cites top-line growth and balance sheet improvement from capital raise.

## SEC filing metadata
- accession: 0001628280-24-035600
- form_type: 8-K
- ticker: PIII
- cik: 0001832511
- company_name: P3 Health Partners Inc.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832511/000162828024035600/0001628280-24-035600-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832511/000162828024035600/piii-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-035600
- JSON: https://secwatch.observer/filing/0001628280-24-035600.json
- Plain text: https://secwatch.observer/filing/0001628280-24-035600.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.